The Glycopeptide PV-PS A1 Immunogen Elicits Both CD4+ and CD8+ Responses
Sharmeen Nishat, Md Kamal Hossain, Geraud Valentin, Farzana Hossain, Shanika Gamage, Katherine A Wall, Peter R Andreana, Walter J Storkus, Swayam Prakash · 2024
Read The Glycopeptide PV-PS A1 Immunogen Elicits Both CD4+ and CD8+ Responses by Sharmeen Nishat, Md Kamal Hossain, Geraud Valentin, Farzana Hossain, Shanika Gamage, Katherine A Wall, Peter R Andreana, Walter J Storkus, Swayam Prakash (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11680115.txt.
Description
Sharmeen Nishat and co-authors engineer a vaccine ingredient that wakes up both arms of T-cell immunity at once. A bacterial sugar called PS A1 is a prized vaccine carrier because it recruits helper T cells through the class II pathway. It cannot, however, summon the killer T cells that class I presentation triggers, a gap for cancer and virus vaccines.
The team stitched a poliovirus peptide, a known class I target, onto a tumor-sugar version of the carrier. Mice immunized with the construct produced both helper and killer responses. A dual-pathway carrier could carry tumor sugars into full immune view. The work extends a platform already in vaccine development.
Catalog record
| CREATOR | Sharmeen Nishat, Md Kamal Hossain, Geraud Valentin, Farzana Hossain, Shanika Gamage, Katherine A Wall, Peter R Andreana, Walter J Storkus, Swayam Prakash |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |